ArticleCell transplantation
Human islet isolation optimization: Insights from donor and isolation procedural factors.
Article in Cell transplantation. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study investigated donor and islet isolation procedural factors influencing the islet yield during human islet isolation for transplantation. We retrospectively analyzed 133 islet isolations from deceased donors performed over 15 years at a single center. Isolations were stratified by post-purification islet yield (≥400,000 islet equivalents [IEQ], successful; <400,000 IEQ, unsuccessful) and by intent (clinical vs research). Higher donor body mass index and height over 170 cm were independently associated with successful isolation, whereas an enzyme perfusion temperature exceeding 14°C for ≥50% of the perfusion duration emerged as an independent risk factor for isolation failure. Clinically intended isolations exhibited tighter thermal control during Phase 1 digestion, greater digestion efficiency, and lower undigested tissue weight. A logistic regression model incorporating body surface area, packed tissue volume, and phase 1 digestion time (the interval from the start of warm recirculation to the collection phase) showed a moderate predictive value for isolation success (area under the curve = 0.755). Subgroup analysis revealed that longer relative phase 2 digestion time (the interval from the start of collection to its end) and higher North American Islet Donor Scores were associated with higher islet yield. These findings highlight the importance of donor anthropometrics, procedural consistency, and thermal regulation during islet isolation. Optimizing donor selection and controlling intra-procedural variables can improve islet yield and increase the likelihood of achieving the required clinical transplantation islet dose.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.